DrugSupplement
Biotin clinical trials
Also written MD1003 and vitamin B7.
- studies test it
- 20
- open now
- 1
- in phase 3
- 5
- first study started
- 2003
Keep track of what changes. Save the Biotin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
20 studies that test it; most in 2019 (5)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 4
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 5
MedDay Pharmaceuticals SA (10) · Nutrition 21, Inc. (3) · Sports Medicine Research and Testing Laboratory (1) · American University of Beirut Medical Center (1) · Dr. med. Mahir Karakas (1) · University of Minnesota (1) · SPD Development Company Limited (1) · University of Arkansas (1)
Often tested with
Tested in the same studies.
Picolinic acid (2) · Silicon (1) · Carnitine (1)
Studies
Open first, then newest update. How each study uses Biotin is read from its arms, and is right about nine times in ten.
Testing it · 20
- Effectiveness of a Novel Dietary Ingredient on Hair Growth and Skin's AppearanceRecruitingNot applicableNutrition 21, Inc.NCT06010745Written as Biotin and silicon
- Can Biotin Supplementation be Used to Mask hCG Abuse?CompletedEarly Phase 1Sports Medicine Research and Testing LaboratoryNCT05450900Written as biotin
- The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent AsthmaStatus unknownPhase 3Tanta UniversityNCT05632549Written as Biotin Capsules
- Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral SclerosisCompletedPhase 2American University of Beirut Medical CenterNCT03427086Written as Biotin
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)TerminatedPhase 3MedDay Pharmaceuticals SANCT02936037Written as MD1003 100mg capsule
- Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male SubjectsCompletedPhase 1MedDay Pharmaceuticals SANCT04223232Written as [14C]-MD1003
- SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot StudyCompletedPhase 2MedDay Pharmaceuticals SANCT02967679Written as MD1003
- Effect of Biotin on Routine Laboratory ValuesCompletedPhase 4Dr. med. Mahir KarakasNCT03995277Written as Biotin
- RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy SubjectsTerminatedPhase 1MedDay Pharmaceuticals SANCT04252430Written as MD1003
- HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy SubjectsTerminatedPhase 1MedDay Pharmaceuticals SANCT04252417Written as MD1003
- TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult SubjectsStatus unknownPhase 1MedDay Pharmaceuticals SANCT04168723Written as MD1003
- Effect of MD1003 in Amyotrophic Lateral SclerosisCompletedPhase 2MedDay Pharmaceuticals SANCT03114215Written as MD1003
- Interference of Biotin Supplementation in Biotin-streptavidin Platforms for Hormone TestingCompletedNot applicableUniversity of MinnesotaNCT03034707Written as biotin
- Biotin Sample Collection StudyCompletedNot applicableSPD Development Company LimitedNCT03746821Written as Biotin
- MD1003-AMN MD1003 in AdrenomyeloneuropathyCompletedPhase 2/3MedDay Pharmaceuticals SANCT02961803Written as MD1003 100 mg capsule
- Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple SclerosisStatus unknownPhase 3MedDay Pharmaceuticals SANCT02220244Written as MD1003 100mg capsule
- Effect of MD1003 in Spinal Progressive Multiple SclerosisStatus unknownPhase 3MedDay Pharmaceuticals SANCT02220933Written as MD1003 100mg capsule
- Biotin Status in PregnancyCompletedNot applicableUniversity of ArkansasNCT00894920Written as biotin
- A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DMCompletedNot applicableNutrition 21, Inc.NCT00308451Written as Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)
- Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DMCompletedNot applicableNutrition 21, Inc.NCT00289354Written as Chromium Picolinate (600 mcg Cr) + biotin (2 mg)
As the comparator · 1 — what is tested is compared with Biotin
Codes
What other systems call Biotin · ClinicalTrials.gg INT007076
- MeSH (NLM) D001710BiotinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6SO6U10H04BIOTINConfirmed FDA, NLM, Wikidata
- RxNorm 1588Confirmed FDA, Wikidata
- Wikidata Q181354biotinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C309BiotinOne source FDA
- DrugBank DB00121One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001710 | Biotin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6SO6U10H04 | BIOTIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1588 | — | Confirmed FDA, Wikidata |
| Wikidata | Q181354 | biotin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C309 | Biotin | One source FDA |
| DrugBank | DB00121 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.